MOLN
Income statement / Annual
Last year (2023), Molecular Partners AG's total revenue was $7.04 M,
a decrease of 96.29% from the previous year.
In 2023, Molecular Partners AG's net income was -$61.98 M.
See Molecular Partners AG’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$7.04 M
|
$189.56 M
|
$9.33 M
|
$9.34 M
|
$20.38 M
|
$10.36 M
|
$20.02 M
|
$23.04 M
|
$29.12 M
|
$26.63 M
|
| Cost of Revenue |
$47.84 M |
$50.75 M |
$55.72 M |
$56.08 M |
$43.50 M |
$15.60 M |
$17.82 M |
$14.57 M |
$1.17 M |
$170,750.00 |
| Gross Profit |
-$40.81 M |
$138.81 M |
-$46.39 M |
-$46.73 M |
-$23.12 M |
-$5.25 M |
$2.19 M |
$8.47 M |
$27.95 M |
$26.45 M |
| Gross Profit Ratio |
-5.8 |
0.73 |
-4.97 |
-5 |
-1.13 |
-0.51 |
0.11 |
0.37 |
0.96 |
0.99 |
| Research and Development
Expenses |
$46.73 M
|
$50.75 M
|
$55.72 M
|
$56.08 M
|
$43.50 M
|
$38.20 M
|
$37.45 M
|
$35.19 M
|
$23.92 M
|
$18.79 M
|
| General & Administrative
Expenses |
$19.00 M
|
$21.82 M
|
$16.91 M
|
$11.03 M
|
$13.16 M
|
$9.46 M
|
$8.28 M
|
$7.24 M
|
$6.22 M
|
$4.90 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$57,000.00
|
$5.23 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$19.00 M
|
$21.82 M
|
$16.91 M
|
$11.03 M
|
$13.16 M
|
$9.46 M
|
$8.28 M
|
$7.24 M
|
$6.22 M
|
$4.90 M
|
| Other Expenses |
$367,000.00 |
$372,000.00 |
$125,000.00 |
$568,000.00 |
$381,000.00 |
-$9.76 M |
-$12.12 M |
-$9.38 M |
$4.16 M |
$4.29 M |
| Operating Expenses |
$65.73 M |
$72.94 M |
$72.75 M |
$67.67 M |
$57.04 M |
$47.77 M |
$45.86 M |
$42.53 M |
$31.34 M |
$24.78 M |
| Cost And Expenses |
$68.15 M |
$72.94 M |
$72.75 M |
$67.67 M |
$57.04 M |
$47.77 M |
$45.86 M |
$42.53 M |
$31.34 M |
$24.78 M |
| Interest Income |
$4.28 M |
$1.14 M |
$99,000.00 |
$367,000.00 |
$1.60 M |
$693,000.00 |
$610,000.00 |
$335,000.00 |
$357,517.00 |
$347,846.00 |
| Interest Expense |
$49,000.00 |
$605,000.00 |
$548,000.00 |
$271,000.00 |
$27,000.00 |
$591,000.00 |
$197,000.00 |
$89,000.00 |
$216.00 |
$853.00 |
| Depreciation &
Amortization |
$2.42 M
|
$2.39 M
|
$2.57 M
|
$2.89 M
|
$2.47 M
|
$924,000.00
|
$1.15 M
|
$1.09 M
|
$909,386.00
|
$809,532.00
|
| EBITDA |
-$58.69 M
|
$120.13 M
|
-$60.76 M
|
-$55.10 M
|
-$32.67 M
|
-$36.27 M
|
-$24.09 M
|
-$18.06 M
|
-$1.02 M
|
$2.99 M
|
| EBITDA Ratio |
-8.34 |
0.63 |
-6.51 |
-5.9 |
-1.6 |
-3.5 |
-1.2 |
-0.78 |
-0.04 |
0.11 |
| Operating Income Ratio
|
-8.68
|
0.62
|
-6.8
|
-6.24
|
-1.8
|
-3.61
|
-1.29
|
-0.85
|
-0.08
|
0.07
|
| Total Other
Income/Expenses Net |
-$876,000.00
|
$1.24 M
|
-$365,000.00
|
-$4.45 M
|
$389,000.00
|
-$218,000.00
|
$1,000.00
|
$628,000.00
|
$1.78 M
|
-$4.46 M
|
| Income Before Tax |
-$61.98 M |
$117.85 M |
-$63.78 M |
-$62.78 M |
-$36.27 M |
-$37.04 M |
-$25.43 M |
-$18.61 M |
-$148,823.00 |
-$2.28 M |
| Income Before Tax Ratio
|
-8.81
|
0.62
|
-6.84
|
-6.72
|
-1.78
|
-3.58
|
-1.27
|
-0.81
|
-0.01
|
-0.09
|
| Income Tax Expense |
$2.25 M |
-$1.24 M |
$2,000.00 |
-$11,000.00 |
$17,000.00 |
-$591,000.00 |
-$414,000.00 |
-$874,000.00 |
-$2.07 M |
$4.12 M |
| Net Income |
-$61.98 M |
$117.85 M |
-$63.79 M |
-$62.76 M |
-$36.29 M |
-$37.04 M |
-$25.43 M |
-$18.61 M |
-$148,823.00 |
-$2.28 M |
| Net Income Ratio |
-8.81 |
0.62 |
-6.84 |
-6.72 |
-1.78 |
-3.58 |
-1.27 |
-0.81 |
-0.01 |
-0.09 |
| EPS |
-1.89 |
3.63 |
-2.06 |
-2.51 |
-1.69 |
-1.75 |
-1.22 |
-0.91 |
-0.0076 |
-0.15 |
| EPS Diluted |
-1.89 |
3.54 |
-2.06 |
-2.51 |
-1.69 |
-1.75 |
-1.22 |
-0.91 |
-0.0076 |
-0.15 |
| Weighted Average Shares
Out |
$32.77 M
|
$32.47 M
|
$31.01 M
|
$25.00 M
|
$21.41 M
|
$21.17 M
|
$20.86 M
|
$20.43 M
|
$19.54 M
|
$15.22 M
|
| Weighted Average Shares
Out Diluted |
$32.77 M
|
$33.27 M
|
$31.01 M
|
$25.00 M
|
$21.41 M
|
$21.17 M
|
$20.86 M
|
$20.43 M
|
$19.54 M
|
$15.29 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
